Related Experiment Video
Updated: Jan 17, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.9K
Cognitive dysfunction and atrophic changes of selected cerebral structures in patients with relapsing-remitting
Małgorzata Szymańska1, Maciej Świat2, Monika Adamczyk-Sowa1
1Department of Neurology Zabrze, Medical University of Silesia in Katowice, Poland.
Postepy Psychiatrii Neurologii
|September 17, 2025
Summary
Brain volume changes correlate with cognitive impairment in early multiple sclerosis (MS) patients. Early neuropsychological testing can help screen for cognitive dysfunction in MS.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease impacting cognitive function.
- Early detection of cognitive impairment is crucial for managing MS.
- Brain structural changes, particularly atrophy, are associated with MS progression.
Purpose of the Study:
- To compare neuropsychological test results with volumetric brain measurements in newly diagnosed MS patients.
- To investigate the relationship between brain atrophy and cognitive deficits at disease onset.
- To establish baseline correlations for future longitudinal studies.
Main Methods:
- 76 newly diagnosed MS patients underwent neuropsychological testing (MSFC, EDSS, cognitive batteries) and brain MRI.
- Volumetric MRI assessed cortex and subcortical structures.
- Assessments were performed at baseline before treatment and after 12 months.
Main Results:
- Positive correlations found between grey matter/cortical volume and cognitive tests (PASAT3", SRT, BVMT-RD, BVMT-R).
- Brain atrophy correlated with specific cognitive impairments, indicating structural-cognitive links.
- No significant correlation between cognitive dysfunction severity and MS duration at baseline.
Conclusions:
- Cognitive domains should be evaluated early in MS patients from disease onset.
- Long-term follow-up of cognitive changes is essential.
- Assessing frequently impaired cognitive domains can serve as a screening tool for MS-related cognitive dysfunction.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Negative and Cognitive Symptoms of Schizophrenia
470
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
470

